Validation of the IPSET Score for Thrombosis in Patients With Prefibrotic Myelofibrosis

Blood Cancer Journal - United States
doi 10.1038/s41408-020-0289-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Incidence and Risk Factors for Bleeding in 1104 Patients With Essential Thrombocythemia or Prefibrotic Myelofibrosis Diagnosed According to the 2008 WHO Criteria

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Practice-Relevant Revision of Ipset-Thrombosis Based on 1019 Patients With WHO-Defined Essential Thrombocythemia

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Prefibrotic Versus Overtly Fibrotic Primary Myelofibrosis: Clinical, Cytogenetic, Molecular and Prognostic Comparisons

British Journal of Haematology
Hematology
2017English

Validation of a New Neurological Score (FOUR Score) in the Assessment of Neurosurgical Patients With Severely Impaired Consciousness

Acta Neurochirurgica
SurgeryNeurology
2013English

Validation of the Fracture Mobility Score Against the Parker Mobility Score in Hip Fracture Patients

Injury
SurgeryOrthopedicsSports MedicineEmergency Medicine
2020English

Validation of Risk Assessment Models for Venous Thrombosis in Hospitalized Medical Patients

Research and Practice in Thrombosis and Haemostasis
2019English

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Prospective Validation of the Objective Prognostic Score for Advanced Cancer Patients in Diverse Palliative Settings

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy